Literature DB >> 23735915

Optimization and expansion of predictive models for Barrett's esophagus and esophageal adenocarcinoma: could a life-course exposure history be beneficial?

Michael B Cook.   

Abstract

Thrift et al. provide preliminary evidence that younger age of symptomatic gastroesophageal reflux disease exposure is associated with increased risk of Barrett's esophagus. If these findings are confirmed in other studies, the next logical steps are to test whether this, and other age-specific exposures, can help optimize predictive models of Barrett's esophagus and progression to esophageal adenocarcinoma. Expansion of these models to the general population and the greater Barrett's esophagus population, respectively, will be required for a screening and surveillance approach to be clinically successful and cost-effective.

Entities:  

Mesh:

Year:  2013        PMID: 23735915     DOI: 10.1038/ajg.2013.83

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  3 in total

Review 1.  Barrett oesophagus in 2013: risk stratification and surveillance in Barrett oesophagus.

Authors:  Emmanuel C Gorospe; Kenneth K Wang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-12-10       Impact factor: 46.802

2.  Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling.

Authors:  Chung Yin Kong; Sonja Kroep; Kit Curtius; William D Hazelton; Jihyoun Jeon; Rafael Meza; Curtis R Heberle; Melecia C Miller; Sung Eun Choi; Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Eric J Feuer; John M Inadomi; Chin Hur; E Georg Luebeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-01       Impact factor: 4.254

3.  High-resolution manometry in patients with and without globus pharyngeus and/or symptoms of laryngopharyngeal reflux.

Authors:  Heyan Ding; Zhijun Duan; Dong Yang; Zhifeng Zhang; Lixia Wang; Xiaoyu Sun; Yiwen Yao; Xue Lin; Hang Yang; Shan Wang; Jiande D Z Chen
Journal:  BMC Gastroenterol       Date:  2017-10-23       Impact factor: 3.067

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.